chr12-95081528-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018351.4(FGD6):āc.4285A>Gā(p.Ile1429Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000374 in 1,605,374 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018351.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGD6 | NM_018351.4 | c.4285A>G | p.Ile1429Val | missense_variant | 21/21 | ENST00000343958.9 | NP_060821.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGD6 | ENST00000343958.9 | c.4285A>G | p.Ile1429Val | missense_variant | 21/21 | 1 | NM_018351.4 | ENSP00000344446.4 | ||
FGD6 | ENST00000451107.3 | n.*1680A>G | non_coding_transcript_exon_variant | 20/20 | 1 | ENSP00000408291.3 | ||||
FGD6 | ENST00000451107.3 | n.*1680A>G | 3_prime_UTR_variant | 20/20 | 1 | ENSP00000408291.3 | ||||
FGD6 | ENST00000548069.5 | c.365A>G | p.Asn122Ser | missense_variant | 4/4 | 3 | ENSP00000448350.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 247764Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134130
GnomAD4 exome AF: 0.0000406 AC: 59AN: 1453250Hom.: 0 Cov.: 28 AF XY: 0.0000332 AC XY: 24AN XY: 722846
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74312
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at